Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 15702-53-1
2. Ccris 3941
3. Magnesium Silicate (mg3si2o7)
4. Dtxsid40166194
Molecular Weight | 149.00 g/mol |
---|---|
Molecular Formula | Mg3O3Si+4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 0 |
Exact Mass | 147.9167955 g/mol |
Monoisotopic Mass | 147.9167955 g/mol |
Topological Polar Surface Area | 63.2 Ų |
Heavy Atom Count | 7 |
Formal Charge | 4 |
Complexity | 18.8 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
ABOUT THIS PAGE
37
PharmaCompass offers a list of CCRIS 3941 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right CCRIS 3941 manufacturer or CCRIS 3941 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred CCRIS 3941 manufacturer or CCRIS 3941 supplier.
PharmaCompass also assists you with knowing the CCRIS 3941 API Price utilized in the formulation of products. CCRIS 3941 API Price is not always fixed or binding as the CCRIS 3941 Price is obtained through a variety of data sources. The CCRIS 3941 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Magnesium silicate (Mg3Si2O7) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Magnesium silicate (Mg3Si2O7), including repackagers and relabelers. The FDA regulates Magnesium silicate (Mg3Si2O7) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Magnesium silicate (Mg3Si2O7) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Magnesium silicate (Mg3Si2O7) supplier is an individual or a company that provides Magnesium silicate (Mg3Si2O7) active pharmaceutical ingredient (API) or Magnesium silicate (Mg3Si2O7) finished formulations upon request. The Magnesium silicate (Mg3Si2O7) suppliers may include Magnesium silicate (Mg3Si2O7) API manufacturers, exporters, distributors and traders.
click here to find a list of Magnesium silicate (Mg3Si2O7) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Magnesium silicate (Mg3Si2O7) Drug Master File in Japan (Magnesium silicate (Mg3Si2O7) JDMF) empowers Magnesium silicate (Mg3Si2O7) API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Magnesium silicate (Mg3Si2O7) JDMF during the approval evaluation for pharmaceutical products. At the time of Magnesium silicate (Mg3Si2O7) JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Magnesium silicate (Mg3Si2O7) suppliers with JDMF on PharmaCompass.
Magnesium silicate (Mg3Si2O7) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Magnesium silicate (Mg3Si2O7) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Magnesium silicate (Mg3Si2O7) GMP manufacturer or Magnesium silicate (Mg3Si2O7) GMP API supplier for your needs.
A Magnesium silicate (Mg3Si2O7) CoA (Certificate of Analysis) is a formal document that attests to Magnesium silicate (Mg3Si2O7)'s compliance with Magnesium silicate (Mg3Si2O7) specifications and serves as a tool for batch-level quality control.
Magnesium silicate (Mg3Si2O7) CoA mostly includes findings from lab analyses of a specific batch. For each Magnesium silicate (Mg3Si2O7) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Magnesium silicate (Mg3Si2O7) may be tested according to a variety of international standards, such as European Pharmacopoeia (Magnesium silicate (Mg3Si2O7) EP), Magnesium silicate (Mg3Si2O7) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Magnesium silicate (Mg3Si2O7) USP).